Glycemic control, weight-loss effects, and safety of cotadutide in individuals with type 2 diabetes: A systematic review and meta-analysis

doi:10.4239/wjd.v16.i12.112830

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-3)

Sum=56

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=14

Dec 15, 2025 (publication date) through Dec 15, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Diabetes. Dec 15, 2025; 16(12): 112830
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.112830

Open in New Tab Full Size Figure Download Figure

Figure 1 Preferred Reporting Items for Systematic reviews and Meta-Analyses flowchart on study retrieval and inclusion in the meta-analysis. T2D: Type 2 diabetes.

Open in New Tab Full Size Figure Download Figure

Figure 2 Forest plot. A: Highlighting the impact of cotadutide as compared to the placebo control group on changes in glycated hemoglobin from baseline; B: Highlighting the impact of cotadutide as compared to the placebo control group on percent changes in body weight from baseline. PCG: Placebo control group; CI: Confidence interval. ^aCI calculated by Wald-type method, ^bTau² calculated by DerSimonian and Laird method.

Citation: Kamrul-Hasan ABM, Dutta D, Nagendra L, Basavarajappa SD, Girijashankar HB, Joshi A, Pappachan JM. Glycemic control, weight-loss effects, and safety of cotadutide in individuals with type 2 diabetes: A systematic review and meta-analysis. World J Diabetes 2025; 16(12): 112830
URL: https://www.wjgnet.com/1948-9358/full/v16/i12/112830.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i12.112830